Phenylketonuria - Clinical trials 

  • Overview
  • Clinical trials
  • Phenylketonuria - Clinical trials - NHS Choices

Clinical trials for Phenylketonuria

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Phenylketonuria. For all clinical trials, go to clinical trials search

This list shows clinical trials for Phenylketonuria

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Phenylketonuria
Title Recruitment status Location
Study of Cicletanine for Pulmonary Arterial Hypertension (PAH) Recruiting United Kingdom
Kuvan® in Phenylketonuria (PKU) Patients Less Than 4 Years Old Recruiting United Kingdom
Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH) Recruiting United Kingdom
A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) Recruiting United Kingdom
Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Patients Recruiting United Kingdom
Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension Recruiting United Kingdom
To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension. Not recruiting United Kingdom
A randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of the addition of inhaled iloprost in patients with pulmonary arterial hypertension (PAH) receiving oral sildenafil - VISION Not Recruiting United Kingdom
Randomized, double-blind, placebo-controlled, multi-centre, multi-national study to evaluate the efficacy and safety of oral BAY 63-2521 (1 mg, 1.5 mg, 2 mg, or 2.5 mg tid) in patients with symptomatic Pulmonary Arterial Hypertension (PAH). - PATENT-1 Study Not Recruiting United Kingdom
A MULTINATIONAL, MULTICENTRE, RANDOMIZED, PARALLEL GROUP, DOUBLE-BLIND STUDY TO ASSESS THE EFFICACY AND SAFETY OF 1 MG, 5 MG AND 20 MG TID OF ORAL SILDENAFIL IN THE TREATMENT OF SUBJECTS AGED 18 YEARS AND OVER WITH PULMONARY ARTERIAL HYPERTENSION (PAH) - N/A Not Recruiting United Kingdom
  • Link to Directgov – public services all in one place
  • The Information Standard - Certified member